WAT Stock Recent News

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

News Summary Enables measurements up to 2 days earlier for antibody titers for both clone selection and bioprocess monitoring.1 Provides up to 7x improvements in sensitivity with novel high efficiency particles.2 Delivers 2x more attribute information with simplified multi-attribute workflows.3 MILFORD, Mass. , May 28, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the launch of the BioResolve™ Protein A Affinity Columns with MaxPeak™ Premier Technology, providing precise titer measurements.

MILFORD, Mass. , May 21, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced that it has acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies.

Norwegian Cruise Line showed a very slight earnings decline in Q1, reflecting a capacity and occupancy decline, offset by a good net yield gain. Macroeconomic headwinds create a more turbulent outlook for NCLH, as consumer weakness has caused more choppy bookings behavior for Q3. Notably, NCLH's performance and guidance both underperform Carnival Corporation and Royal Caribbean Cruises, making the company's commercial performance unclear.

MILFORD, Mass. , May 16, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.

U.S.-based Waters Corp , which makes medical equipment used in clinical testing, has seen a spurt in demand from drugmakers in India rushing to develop their versions of popular weight-loss drugs, a senior executive told Reuters.

WAT's first-quarter 2025 results reflect strong growth in the instruments and chemical segments, coupled with strong momentum in the industrial and pharma sectors.

Waters Corporation's stock remains a "Hold" due to high valuation multiples, despite a 35% increase in stock price and improved business performance. The company reported solid Q1 2025 results, with 3.9% revenue growth and 18% EPS growth, but valuation remains above historical averages. Management is optimistic about future growth, citing opportunities in the Indian market, GLP-1 testing, and pricing strategies, expecting high single-digit revenue growth.

Waters Corporation (NYSE:WAT ) Q1 2025 Earnings Conference Call May 6, 2025 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President and Chief Executive Officer Amol Chaubal - Senior Vice President and Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research LLC Tycho Peterson - Jefferies Puneet Souda - Leerink Partners Catherine Schulte - Robert W. Baird & Co. Sung Ji Nam - Scotiabank Global Banking and Markets Brandon Couillard - Wells Fargo Securities LLC Vijay Kumar - Evercore ISI Matthew Sykes - Goldman Sachs Group, Inc. Daniel Arias - Stifel, Nicolaus & Company Daniel Brennan - TD Cowen Operator Good morning.

Although the revenue and EPS for Waters (WAT) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.